deoxypyridinoline has been researched along with Neurofibromatosis 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, JM; Friedrich, RE; Frieling, I; Hartmann, M; Kruse, HP; Mautner, VF; Schnabel, C; Tucker, T | 1 |
| Carey, JC; D'Astous, JL; Firth, SD; Moyer-Mileur, LJ; Murray, M; Pasquali, M; Schwarz, EL; Stevenson, DA; Viskochil, DH | 1 |
2 other study(ies) available for deoxypyridinoline and Neurofibromatosis 1
| Article | Year |
|---|---|
Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1).
Topics: Acid Phosphatase; Adult; Aged; Amino Acids; Animals; Bone Density; Bone Diseases, Metabolic; Calcium; Female; Fractures, Bone; Humans; Isoenzymes; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neurofibromatosis 1; Osteoporosis; Parathyroid Hormone; Phosphates; Tartrate-Resistant Acid Phosphatase; Vitamin D; Young Adult | 2009 |
Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis.
Topics: Adolescent; Amino Acids; Biomarkers; Bone Resorption; Case-Control Studies; Child; Child, Preschool; Collagen; Humans; Musculoskeletal Abnormalities; Neurofibromatosis 1; Up-Regulation | 2008 |